Integer Holdings (ITGR)
(Delayed Data from NYSE)
$131.49 USD
-0.94 (-0.71%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $131.54 +0.05 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$131.49 USD
-0.94 (-0.71%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $131.54 +0.05 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum B VGM
Zacks News
Boston Scientific's (BSX) DBS System Gets FDA's Clearance
by Zacks Equity Research
The latest FDA approval of Boston Scientific's (BSX) fourth-generation Vercise Genus DBS System is aimed at improving patients' quality of life.
Here's Why You Should Retain Integer Holdings (ITGR) Stock Now
by Zacks Equity Research
Integer Holdings (ITGR) continues to gain traction from portfolio management. However, intense competition is a woe.
Here's Why You Should Avoid Betting on Integer Holdings (ITGR)
by Zacks Equity Research
Stiff competition in the MedTech space and weak segmental and operational third-quarter 2020 performance weighs on Integer Holdings (ITGR).
Integer Holdings (ITGR) Q3 Earnings Beat Estimates, Down Y/Y
by Zacks Equity Research
Integer Holdings' (ITGR) third-quarter results reflect weak segmental performance.
Integer (ITGR) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Integer (ITGR) delivered earnings and revenue surprises of 56.25% and 2.72%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Integer (ITGR) Q3 Earnings Expected to Decline
by Zacks Equity Research
Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Avoid Betting on Integer Holdings Now
by Zacks Equity Research
Stiff competition in the MedTech space and weak segmental and operational performance weighs on Integer Holdings (ITGR).
Integer (ITGR) Up 2.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Integer (ITGR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Integer Holdings (ITGR) Q2 Earnings Miss Estimates, Down Y/Y
by Zacks Equity Research
Integer Holdings' (ITGR) second-quarter results reflect from weak segmental performance and margin contraction.
Integer (ITGR) Q2 Earnings Miss Estimates
by Zacks Equity Research
Integer (ITGR) delivered earnings and revenue surprises of -20.00% and 1.87%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Integer (ITGR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Integer Holdings Stock for Now
by Zacks Equity Research
Integer Holdings (ITGR) continues to gain traction from solid presence in the broader MedTech space and portfolio management.
Why Is Integer (ITGR) Up 9.8% Since Last Earnings Report?
by Zacks Equity Research
Integer (ITGR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Integer Holdings (ITGR) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Integer Holdings' (ITGR) first-quarter results benefit from strength in Cardio & Vascular sub-segment and margin expansion.
Integer (ITGR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Gibraltar Industries, CBIZ, Integer, BioSpecifics Technologies and DHT
by Zacks Equity Research
Zacks.com featured highlights include: Gibraltar Industries, CBIZ, Integer, BioSpecifics Technologies and DHT
Check These 7 Top-Ranked Stocks With Solid Net Profit Margins
by Anirudha Bhagat
Let's take a look at the seven top-ranked stocks with impressive net profit margins for a winning portfolio.
The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group
5 Stocks to Buy for 5 Good Reasons
by Sejuti Banerjea
Here are 5 ways to make the most of a difficult market.
Here's Why You Should Add Integer Holdings to Your Portfolio
by Zacks Equity Research
Integer Holdings (ITGR) continues to gain traction from solid presence in the broader MedTech space and portfolio management.
Find Strong Stocks During the Coronavirus Crisis with this Filtered Zacks Rank 5 Screener
by Benjamin Rains
Today we are going to utilize our Filtered Zacks Rank 5 Screener to help investors find what could be solid investments when stocks start to recover...
Why Is Integer (ITGR) Down 48.3% Since Last Earnings Report?
by Zacks Equity Research
Integer (ITGR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Integer Holdings (ITGR) Stock a Solid Choice Right Now?
by Zacks Equity Research
Integer Holdings (ITGR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
The Zacks Analyst Blog Highlights: AAON, Business First, Himax Technologies, Integer Holdings and The Simply Good Foods Company
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AAON, Business First, Himax Technologies, Integer Holdings and The Simply Good Foods Company
Bull & Bear Tug O' War Lingers On: Here's How to Play It
by Tirthankar Chakraborty
Bearish investors argue that that the market is over-stretched and its weakness started after the coronavirus outbreak and its subsequent impact on corporate profit margins and the economy.